Skip to main content
Figure 1 | Journal of Clinical Bioinformatics

Figure 1

From: Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/Visfatin/NMPRTase for glioma therapy

Figure 1

Crystal poses of the Control compounds and docked poses of the identified compounds. Crystallographically observed binding modes of the known and new ligands in NMPRTase; (a) NMN, (b) FK866, and docked binding modes of compounds 4 and 5. (c) and (e) panels indicate the first binding modes of compounds 5 and 4 respectively while panels (d) and (f) indicate the second binding modes of compounds 5 and 4 respectively. The ligands are in ball and stick representation and colored by standard atom types; the A chain residues of the site are shown in red and C chain residues are in blue, in all the panels.

Back to article page